You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 98 No. 12, December 1980 TABLE OF CONTENTS
  Archives
  •  Online Features
  LABORATORY SCIENCES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (19)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fluorophotometry

III. Streptozocin-Treated Rats and Rats With Pancreatectomy

Ronald Klein, MD; Ingolf I. H. Wallow, MD; J. Terry Ernest, MD, PhD

Arch Ophthalmol. 1980;98(12):2235-2237.


Abstract

• To determine whether elevated vitreous fluorescence levels are a result of a direct ocular toxic effect of streptozocin or a consequence of the diabetic state, we compared hyperglycemic streptozocinand insulin-treated or non-insulintreated rats, hyperglycemic rats with pancreatectomy, and normal rats. Streptozocin, 65 mg/kg, was injected intravenously in one group of hooded rats, and pancreatectomy was performed on another group of hooded rats. Eight to 16 days later, fluorescein sodium, 16.6 mg/kg, was injected in the femoral vein of 21 hyperglycemic rats and 18 normal animals. One hour later, the aqueous, vitreous, and plasma fluorescence levels were measured using fluorophotometry. We did not find a significant difference between vitreous fluorescence levels of the hyperglycemic streptozocin- and insulintreated or non-insulin-treated and normal rats. Moreover, we did not find a significant difference between the vitreous fluorescence of hyperglycemic rats with pancreatectomy and normal rats.



Author Affiliations

From the Department of Ophthalmology, University of Wisconsin School of Medicine, Madison.


Footnotes

Accepted for publication March 24, 1980.

Reprint requests to the Department of Ophthalmology, University of Wisconsin, Clinical Sciences Center, 600 Highland Ave, Madison, WI 53792 (Dr Klein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Mechanism of Blood-Retinal Barrier Breakdown in Diabetes
Frank
Arch Ophthalmol 1985;103:1303-1304.
ABSTRACT  

Blood-Ocular and Blood-Brain Barrier Function in Streptozocin-Induced Diabetes in Rats
Maepea et al.
Arch Ophthalmol 1984;102:1366-1369.
ABSTRACT  

Effect of Insulin Treatment on the Blood-Retinal Barrier in Rats With Streptozocin-Induced Diabetes
Kernell and Arnqvist
Arch Ophthalmol 1983;101:968-970.
ABSTRACT  

Vitreous Fluorophotometry in the Alloxan- and Streptozocin-Treated Rat
Jones et al.
Arch Ophthalmol 1982;100:1141-1145.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.